US Stock MarketDetailed Quotes

PKBOW PEAK BIO INC C/WTS 26/10/2027 (TO PUR COM)

Watchlist
  • 0.179
  • 0.0000.00%
Close Jan 9 16:00 ET
0Market Cap0.00P/E (TTM)

About PEAK BIO INC C/WTS 26/10/2027 (TO PUR COM) Company

Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease. The company is headquartered in Pleasanton, CA.

Company Profile

SymbolPKBOW
Company NamePEAK BIO INC C/WTS 26/10/2027 (TO PUR COM)
Listing DateMar 15, 2021
Founded2016
CEOMr. Stephen LaMond, M.B.A.,Pharm.D.
MarketNASDAQ
Securities TypeOrdinary Shares
Address4900 Hopyard Road,Suite 100
CityPleasanton
ProvinceCalifornia
CountryUnited States of America
Zip Code94588
Websitehttps://www.peak-bio.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephen LaMond, M.B.A.,Pharm.D.
  • Interim Chief Executive Officer, Chief Operating Officer, Secretary and Director
  • --
  • Timothy M. Cunningham
  • Acting Chief Financial Officer
  • --
  • Dr. Hoyoung Huh,M.D.,PhD
  • Director
  • --
  • Satyajit Kumar Mitra
  • Executive Director and Head of Oncology
  • --
  • Nevan Charles Elam, J.D.
  • Lead Independent Director
  • --
  • James R. Neal, M.B.A.,M.S.
  • Independent Director
  • --
  • David I. Rosenberg
  • Independent Director
  • --
  • Brad Stevens
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg